Riskpilot← Back to searchSign inGet full accessDawn Health Dubai ApS
APSIn liquidationCVR 41664878Sundkaj 153, 1. thComputer programming activities · NACE 6210Est. 2020— employees
Revenue 2024
DKK -8K
-99% vs 2023
EBITDA margin
100.0%
+99% vs 2023
Equity ratio
-1670.7%
Financial strength
Net profit 2024
DKK -236K
+73% vs 2023
| Revenue | DKK -8K | -99% |
| EBITDA | DKK -8K | +99% |
| Net profit | DKK -236K | +73% |
| Total assets | DKK 106K | -99% |
| Equity | DKK -1,8M | -15% |
| Employees | — | — |
Legal name
Dawn Health Dubai ApS
CVR number
41664878
Legal form
Anpartsselskab
NACE code
6210 · Computer programming activities
Founded
10. september 2020
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at eje og investere i kapitalandele i andre selskaber samt at drive virksomhed med udvikling og salg af software, rådgivning samt hermed forbundet virksomhed.
Address
Sundkaj 153, 1. th
Phone
+4528942886
Email
alh@dawnhealth.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 4.045 | 6.416 | -731 | -8 |
| Staff expenses | -3.066 | -7.171 | -493 | -0 |
| EBITDA | 979 | -756 | -1.224 | -8 |
| Depreciation & amort. | -1 | -19 | -0 | -0 |
| EBIT | 978 | -775 | -1.224 | -8 |
| Net financials | -109 | -790 | 461 | -233 |
| Profit before tax | 869 | -1.565 | -763 | -241 |
| Tax | -0 | -6 | 124 | -4 |
| Net profit | 869 | -1.559 | -887 | -236 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 5.645 | 8.964 | 9.116 | 106 |
| Equity | 909 | -650 | -1.537 | -1.774 |
| Long-term debt | 0 | 8.599 | 10.520 | 1.870 |
| Short-term debt | 4.736 | 1.016 | 133 | 9 |
| Total debt | 4.736 | 9.615 | 10.653 | 1.880 |
EBITDA margin
-794300.0%
This company
15.8%
Market median
-5027315% vs market
20212024
Equity ratio
-1670.7%
This company
38.2%
Market median
-4474% vs market
20212024
Return on equity
-23645100.0%
This company
18.4%
Market median
-128506078% vs market
20212024
Net profit margin
-23645100.0%
This company
8.1%
Market median
-291914915% vs market
20212024
Asset turnover
-0.07×
This company
1.12×
Market median
-106% vs market
20212024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-09-10 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AH Unofficial title | Unofficial title | 2026 |
| Former (1) | ||
DG Chief Executive Officer | Chief Executive Officer | 2020 – 2026 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AUGUSTINUS FONDENCHR. AUGUSTINUS FABRIKKER AKTIESELSKABDawn Holding ApS
Dawn Health Dubai ApS (this company)Board members of Dawn Health Dubai ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Hagstrøm | Unofficial title | 0 companies |
| Daniel Gewecke Daugaard-Jensen | Chief Executive Officer | 0 companies |